Dr. Paul Stoffels, Chief Scientific Officer of Johnson & Johnson, discusses his company's COVID-19 vaccine. He talks about J&J's one-shot vaccine generating strong protection against Covid-19 in a large, late-stage trial.
Hosts: Carol Massar and Tim Stenovec. Producer: Doni Holloway.

Bloomberg Businessweek Weekend - March 13th, 2026
41:18

Judge Rejects Subpoenas of Fed Board in Powell Case
38:43

Private Credit’s ‘Back Leverage’ Is Another Pain Point for Funds
10:47